| Identification | Back Directory | [Name]
3-Isoxazolecarboxamide,N-(2,6-dimethylphenyl)-5-(hydroxymethyl)- | [CAS]
130403-18-8 | [Synonyms]
3-Isoxazolecarboxamide,N-(2,6-dimethylphenyl)-5-(hydroxymethyl)- | [Molecular Formula]
C13H14N2O3 | [MOL File]
130403-18-8.mol | [Molecular Weight]
246.262 |
| Hazard Information | Back Directory | [Uses]
D3017 is the main metabolite of D2624, which has oral bioactivity and anti-convulsant effects. D3017 ED50 value is 1.5 mg/kg in mice, and it can be used for research on severe generalized tonic-clonic seizures (grand mal) and complex partial epilepsy[1]. | [References]
[1] F Lepage, et al. New N-aryl isoxazolecarboxamides and N-isoxazolylbenzamides as anticonvulsant agents. Eur JMed Chem (1992) 27,581-593. |
|
| Company Name: |
TargetMol
|
| Telephone: |
400-821-0310 15002144251 |
| Website: |
www.targetmol.cn/ |
|